BridgeMD
New treatment option for Visceral Pain
Official title Intraoperative Autonomic Blockade for Laparoscopic Cholecystectomy
ClinicalTrials.gov ID: NCT06753500
What this study is testing
- What it's testing
- This study proposes infiltrating the hepatoduodenal ligament and the serosal reflection of the gallbladder cystic plate with a combination of Bupivacaine (a long-acting local anesthetic) and Dexamethasone (a corticosteroid). This technique aims to block the hepatic branches of the celiac plexus to improve visceral pain control and its associated clinical manifestations, reduce analgesic requirements, and lower readmission rates, thereby facilitating recovery.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Elective or emergency laparoscopic cholecystectomy for cholelithiasis with or without cholecystitis.
You likely can't join if
- Associated biliary pathologies (e.g., biliary pancreatitis, cholangitis).
- Additional procedures, such as formal bile duct exploration. Conversion to an open approach
- Anesthesia or Surgical complications that require intensive care unit
- Allergies to local anesthetics
The study team makes the final eligibility decision.
Where it's taking place
- Barranquilla, Atlantivo, Colombia
- Barranquilla, Atlántico, Colombia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barranquilla, Atlantivo, Colombia; Barranquilla, Atlántico, Colombia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.